132 related articles for article (PubMed ID: 2663614)
1. Ovarian carcinoma as a cause of Zollinger-Ellison syndrome. Natural history, secretory products, and response to provocative tests.
Maton PN; Mackem SM; Norton JA; Gardner JD; O'Dorisio TM; Jensen RT
Gastroenterology; 1989 Aug; 97(2):468-71. PubMed ID: 2663614
[TBL] [Abstract][Full Text] [Related]
2. Zollinger-Ellison syndrome due to a gastrin-producing ovarian cystadenocarcinoma.
Bollen EC; Lamers CB; Jansen JB; Larsson LI; Joosten HJ
Br J Surg; 1981 Nov; 68(11):776-7. PubMed ID: 7296246
[No Abstract] [Full Text] [Related]
3. Ovarian mucinous cystadenocarcinoma as a cause of Zollinger-Ellison syndrome: report of a case and review of the literature.
Hirasawa K; Yamada M; Kitagawa M; Takehira Y; Tamakoshi K; Nakamura T; Kawamura K; Takagi M; Murohisa B; Ozawa T; Hanai H; Kaneko E
Am J Gastroenterol; 2000 May; 95(5):1348-51. PubMed ID: 10811352
[TBL] [Abstract][Full Text] [Related]
4. Gastrin-producing ovarian mucinous cystadenomas: a cause of the Zollinger-Ellison syndrome.
Primrose JN; Maloney M; Wells M; Bulgim O; Johnston D
Surgery; 1988 Nov; 104(5):830-3. PubMed ID: 3187898
[TBL] [Abstract][Full Text] [Related]
5. Zollinger-Ellison syndrome due to gastrin-secreting ovarian cystadenocarcinoma. Case report.
Boixeda D; Lopez-San Roman A; Pascasio JM; Erdozain JC; Perez-Hernandez F; Garcia-Villanueva M; Hernandez-Ranz F
Acta Chir Scand; 1990 May; 156(5):409-10. PubMed ID: 2349859
[TBL] [Abstract][Full Text] [Related]
6. Gastrin-producing ovarian cystadenocarcinoma: sensitivity to secretin and SMS 201-995.
Heyd J; Livni N; Herbet D; Mor-Yosef S; Glaser B
Gastroenterology; 1989 Aug; 97(2):464-7. PubMed ID: 2473000
[TBL] [Abstract][Full Text] [Related]
7. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
Berna MJ; Hoffmann KM; Long SH; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):331-364. PubMed ID: 17108779
[TBL] [Abstract][Full Text] [Related]
8. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
Pisegna JR; Norton JA; Slimak GG; Metz DC; Maton PN; Gardner JD; Jensen RT
Gastroenterology; 1992 Mar; 102(3):767-78. PubMed ID: 1537514
[TBL] [Abstract][Full Text] [Related]
9. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.
Fishbeyn VA; Norton JA; Benya RV; Pisegna JR; Venzon DJ; Metz DC; Jensen RT
Ann Intern Med; 1993 Aug; 119(3):199-206. PubMed ID: 8323088
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
[TBL] [Abstract][Full Text] [Related]
11. Zollinger-Ellison syndrome caused by a mucinous cystadenocarcinoma of the ovary.
Connell WR; Price JD; Lowe DG; Shepherd JH; Farthing MJ
Aust N Z J Med; 1993 Oct; 23(5):520-1. PubMed ID: 8297284
[No Abstract] [Full Text] [Related]
12. Zollinger-Ellison syndrome due to a gastrin secreting ovarian mucinous cystadenoma. Case report.
Morgan DR; Wells M; MacDonald RC; Johnston D
Br J Obstet Gynaecol; 1985 Aug; 92(8):867-9. PubMed ID: 4027214
[No Abstract] [Full Text] [Related]
13. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study.
Frucht H; Howard JM; Slaff JI; Wank SA; McCarthy DM; Maton PN; Vinayek R; Gardner JD; Jensen RT
Ann Intern Med; 1989 Nov; 111(9):713-22. PubMed ID: 2572194
[TBL] [Abstract][Full Text] [Related]
14. Calcium and secretin as provocative stimuli in the Zollinger-Ellison syndrome.
Mihas AA; Hirschowitz BI; Gibson RG
Digestion; 1978; 17(1):1-10. PubMed ID: 627316
[TBL] [Abstract][Full Text] [Related]
15. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome.
Jansen JB; Lamers CB
Gastroenterology; 1982 Jul; 83(1 Pt 2):173-8. PubMed ID: 6806138
[TBL] [Abstract][Full Text] [Related]
16. Abnormal pancreatic polypeptide release by secretin infusion in Zollinger-Ellison syndrome.
Rigaud D; Accary JP; Mignon M; Bonfils S
Dig Dis Sci; 1984 Aug; 29(8):696-702. PubMed ID: 6745029
[TBL] [Abstract][Full Text] [Related]
17. Conservative management of the Zollinger-Ellison syndrome. Ectopic gastrin production by an ovarian cystadenoma.
Long TT; Barton TK; Draffin R; Reeves WJ; McCarty KS
JAMA; 1980 May; 243(18):1837-9. PubMed ID: 7365959
[TBL] [Abstract][Full Text] [Related]
18. Zollinger-Ellison syndrome due to a borderline mucinous cystadenoma of the ovary.
Garcia-Villanueva M; Badia Figuerola N; Ruiz del Arbol L; Hernandez Ortiz MJ
Obstet Gynecol; 1990 Mar; 75(3 Pt 2):549-52. PubMed ID: 2304735
[TBL] [Abstract][Full Text] [Related]
19. Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome.
Mozell E; Woltering EA; O'Dorisio TM; Fletcher WS; Sinclair AJ; Hill D
Surg Gynecol Obstet; 1990 Jun; 170(6):476-84. PubMed ID: 2188384
[TBL] [Abstract][Full Text] [Related]
20. [Zollinger-Ellison syndrome].
Becker HD
Wien Klin Wochenschr; 1984 Feb; 96(4):138-44. PubMed ID: 6324497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
